Thursday, October 08, 2015
Institute of Human Virology Begins Phase 1 Clinical Trials of HIV Vaccine Candidate
Maryland Lt. Governor Boyd Rutherford announced today that the Institute of Human Virology (IHV) at the University of Maryland School of Medicine launched its Phase 1 clinical trials of a novel HIV vaccine candidate developed by a research team led by Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor of Medicine and Director of IHV.
Tuesday, September 29, 2015
Institute of Human Virology Hosts International Meeting of Prominent AIDS Researchers
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine is hosting IHV’s 17th Annual International Meeting Sunday, September 27 through Wednesday, September 30 at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland.
Thursday, September 24, 2015
Institute of Human Virology Co-Founder William Blattner, MD to Retire
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today the retirement of IHV co-founder and associate director, William A. Blattner, MD effective January 31, 2016.
Tuesday, September 01, 2015
University of Maryland Medicine Tests Novel Treatment for Parkinson's
University of Maryland Medicine (the University of Maryland Medical Center and the University of Maryland School of Medicine) and its Center for Metabolic Imaging and Image-Guided Therapeutics (CMIT) has begun to use MRI-guided focused ultrasound on a deep structure within the brain related to Parkinson’s disease – the globus pallidus.
Sunday, August 02, 2015
Institute of Human Virology Works to Reduce HIV in Baltimore
In Baltimore, one in 43 people over the age of 13 is infected with HIV, according to the Maryland Department of Health and Mental Hygiene. Most of the time, those that are infected fail to or are unable to seek proper care. Youth ages 13-24 are the fastest growing group of new HIV infections. Over 50 percent of youth with HIV do not know they are infected.
Tuesday, June 23, 2015
Institute of Human Virology (IHV) Awarded $24.5M to Fight Botswana’s AIDS Epidemic
The Institute of Human Virology (IHV) at the University of Maryland School of Medicine has received a five-year $24.5 million grant from the U.S. Centers for Disease Control and Prevention (CDC) through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to partner with the Government of Botswana and impact the HIV/AIDS epidemic in Botswana, and to demonstrate that comprehensive HIV/AIDS treatment programs can stop the epidemic. PEPFAR is a $48 billion initiative launched in 2004 by former President George W. Bush, and continued by President Barack Obama, to combat major infectious diseases around the world, including HIV.
Monday, June 22, 2015
City Uprising Health Fair to Mark National HIV Testing Day
The JACQUES Initiative, a program of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, in partnership with Greater Than AIDS, Community (a Walgreens Pharmacy), Lexington Pharmacy, HopeSprings and the Gallery Church of Baltimore, is launching Baltimore’s 7th Annual City Uprising Health Fair on June 25-27 to commemorate this year’s National HIV Testing Day designated on June 27.
Friday, May 01, 2015
Baltimore Sun Op-Ed by Robert Gallo et al:
Building local capacity to fight epidemics
Tuesday, April 21, 2015
The Institute of Human Virology and the University of Maryland School of Medicine Appoint New Director of Development
The Institute of Human Virology (IHV) and the University of Maryland School of Medicine recently appointed Lori Piccolo as Director of Development at IHV, an institute of the School of Medicine. This newly created position will lead the fundraising efforts of the IHV, the first center in the United States - perhaps the world - to combine the disciplines of basic science, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably HIV, the cause of AIDS.
Wednesday, April 15, 2015
Innovative Prevention Program in East Africa Seeks to Ensure Access to Care for Addicts with HIV
Heroin addiction is a growing problem in Kenya and Tanzania. Both countries are key transit points in the international heroin trade, and in recent years, increasing numbers of people in both countries are becoming addicted.